Covaxin gets emergency use approval for children 2-18 years old |
News and Updates
eMediNexus Coverage from: 
Covaxin gets emergency use approval for children 2-18 years old

0 Read Comments                

The subject expert committee of the national drugs regulator has given emergency use approval for Covaxin in children aged 2 to 18 years. An official stated that the efficacy of the vaccine among children has been found to be similar to that in adults. A decision on whether it will be included in the national vaccination program is yet to be taken. This is the second vaccine against COVID-19 to be approved for emergency use among children in India after ZyCoV-D, which is to be administered ...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now